Pre-clinical development and phase 1 cmc readiness of a novel

Times are shown in your local time zone GMT

Pre-clinical development and phase 1 cmc readiness of a novel vaccine-dissolving microneedle patch to improve outbreak response and vaccine equity

General

Edit Your Submission

General

3:20 pm

12 May 2025

Boulevard Auditorium

Clinical Research and Market Access

Speakers

Mr Sebastien Henry

EVP, Head of Technical Operations

Micron Biomedical, Inc - Smyrna, United States

Authors

Submission Authors

Mr Sebastien Henry -